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Soluble intracellular adhesive molecule 1 (sICAM-1) and tumour necrosis factor receptors I (TNFR-1) and II (TNFR-II) have been
shown to be associated with numerous liver disorders. Shedding of these membrane proteins can be triggered by the Th1 cytokines, TNF-
alpha and IFN-gamma, which are associated with susceptibility or resistance to hepatic schistosomiasis, respectively. Further, TNF-
alpha receptors and sICAM-1 have been implicated in periportal ﬁbrosis in advanced human schistosomiasis mansoni and correlate with
schistosome granuloma formation in the murine model. We measured serum levels of sICAM-1, TNFR-I and TNFR-II in Chinese
patients with diﬀerent clinically deﬁned stages of schistosomiasis japonica and controls; these included 35 patients with acute schistoso-
miasis, 45 patients with chronic schistosome infections, 34 advanced patients with evidence of severe morbidity and 20 patients with no
known history of exposure to infection. Markedly elevated levels of soluble TNFRs (sTNFRs) and sICAM-1 were observed in the acute
and advanced patients compared with the chronic and control groups. Mean sTNFR-II levels were signiﬁcantly higher in acute patients
compared with advanced (P < 0.00001) and chronic patients (P < 0.00001) and showed the strongest association of the markers with
acute disease (odds ratio (OR) = 1.099). sTNFR-II and sICAM-1 levels both correlated with infection intensity and there were signiﬁcant
positive correlations observed between eosinophil count and infection intensity (P = 0.0072) and sICAM-1 (P = 0.0014). Although there
were signiﬁcantly higher levels of antigen-speciﬁc IgG4 and total IgG in infected individuals compared with controls, none correlated
with infection intensity. Further, no diﬀerences in IgG4 and total IgG levels were observed between the acute and chronic groups.
The results suggest sTNFRs and sICAM-1 are associated with liver inﬂammation and disease progression. Measurement of sTNFR-
II and sICAM-1 levels in serum could serve as additional markers for the diagnosis of acute stage disease and the monitoring of hepatic
inﬂammation in human schistosomiasis japonica.
 2007 Australian Society for Parasitology Inc. Published by Elsevier Ltd.
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Schistosomiasis japonica, caused by Schistosoma
japonicum, is known to have several clinical stages of dis-
ease which are a direct result of an immunopathological0020-7519  2007 Australian Society for Parasitology Inc. Published by Elsev
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E-mail address: Magda.Ellis@qimr.edu.au (M.K. Ellis).reaction to the deposition of eggs in vital organs of the
host, particularly the liver and spleen. The eggs initiate
the onset of acute infection characterised by non-speciﬁc
symptoms including fever and eosinophilia and in some
cases hepato-splenic inﬂammation and mild forms of dif-
fuse ﬁbrosis (Ross et al., 2007). Long-term eﬀects of infec-
tion or repeated re-infection and subsequent accumulation
of the egg-induced granuloma in the liver can be observed
in chronic and, more predominantly, advanced patients.ier Ltd. Open access under CC BY license. 
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result of large collagen deposits in the periportal spaces
leading to portal hypertension, splenomegaly, shunting
and gastrointestinal varices (Ross et al., 2002; Gryseels
et al., 2006).
Granuloma formation is controlled and modulated by
several cell types and protein interactions, primarily
CD4+ T-cells, Th1 cytokines and cell adhesion factors
(Wynn and Cheever, 1995; Jacobs and Van Marck, 1998;
Stadecker et al., 2004). Intracellular adhesion molecule 1
(ICAM-1) is present on endothelial cells, antigen presenting
cells and ﬁbroblasts and belongs to the immunoglobulin
superfamily of proteins (Springer, 1990; Jacobs and Van
Marck, 1998; Zaremba and Losy, 2002). It is well estab-
lished that the Th1 cytokines, IFN-gamma and TNF-alpha,
both trigger the release of soluble ICAM-1 (sICAM-1)
(Momosaki et al., 1995; Paolieri et al., 1997; Leung, 1999)
and are known to play key roles in the modulation (Dessein
et al., 2004; Bonnard et al., 2006) and aggravation of hepa-
tic ﬁbrosis (Henri et al., 2002; Booth et al., 2004), respec-
tively. The soluble form of ICAM-1 is involved in
lymphocyte and eosinophil recruitment and inﬂammatory,
immune-mediated mechanisms (Kyan-Aung et al., 1991;
Radi et al., 2001; Forbes et al., 2006). Raised levels of
sICAM-1 have been observed in the serum of patients with
acute and chronic liver disorders (Abdalla et al., 2002). Ele-
vated expression has also been associated with intestinal
schistosome infection and early granuloma formation in
murine studies (Ritter et al., 1993; Ritter and McKerrow,
1996; El-Ahwany et al., 2000; Hassanein et al., 2001).
sICAM-1 also plays a role in modulation of the schistosome
granuloma (Jacobs and Van Marck, 1998). Further, the
granulomatous response is mediated by eosinophils, the
recruitment of which is critically dependent on ICAM-1
(Teixeira et al., 2001; Forbes et al., 2006). Human studies
have also noted a signiﬁcant increase in sICAM-1 levels in
serum and plasma of hepatic schistosomiasis patients (Secor
et al., 1994; Esterre et al., 1998; Mwatha et al., 1998).
TNF-alpha is thought to aggravate hepatic ﬁbrosis
caused by Schistosoma mansoni (Henri et al., 2002; Booth
et al., 2004). TNF-alpha initiates shedding of the mem-
brane receptors TNFR-I and II which are cleaved from
the membrane and are detectable in serum, plasma and
urine (Fernandez-Botran, 1999; Fernandez-Real et al.,
1999; Dri et al., 2000). Given this relationship, levels of sol-
uble TNFRs (sTNFRs) could reﬂect TNF-alpha activity.
As receptor levels remain elevated longer than TNF-alpha,
they have shown potential as markers of disease progres-
sion in human schistosomiasis (Mwatha et al., 1998) and
have been implicated in schistosome oviposition and circu-
moval granuloma formation in murine studies (Haseeb
et al., 2001).
Immunoglobulins IgG and subclass IgG4 have been
shown to have a pivotal role in the humoral response to
schistosomal infection. A few studies have reported that
measurement of these antibodies can be used to diﬀerenti-
ate between diﬀerent disease stages, in particular acute andchronic patients (Kirinoki et al., 2003; Beck et al., 2004).
High levels of IgG4 have also been associated with peripor-
tal ﬁbrosis and portal hypertension in patients with
advanced schistosomiasis mansoni (Tawfeek et al., 2003).
Here, we report on the serum levels of sICAM-1,
sTNFR-I and sTNFR-II in patients with diﬀerent clinically
deﬁned stages of schistosomiasis japonica as the basis for
investigating their role in schistosome-induced human
hepatic disease. In addition, total IgG and IgG4 levels were
assessed to investigate their potential in the diﬀerential
diagnosis of disease stage.
2. Materials and methods
2.1. Study patients
The study involved 127 participants from endemic areas
of the Poyang and Dongting lakes in Jiangxi and Hunan
provinces, China, respectively, with diﬀerent clinical stages
of schistosomiasis (Table 1), deﬁned according to the
guidelines established by the Ministry of Public Health in
China (Chen and Mott, 1988; MPHC, 2001).
Thirty-ﬁve subjects were diagnosed with acute disease.
These individuals had all tested egg-positive after stool
examination using the Kato-Katz (Katz et al., 1972) thick
smear technique, by serology using indirect haemagluttina-
tion and ELISA assays with soluble egg antigen (SEA) and
soluble worm adult protein (SWAP) (MPHC, 2001). They
also had a clear history of recent water contact and pre-
sented clinical symptoms associated with acute infection
including fever, cough, bloody diarrhoea and eosinophilia
(P15% of their total leukocyte count). Forty-ﬁve patients
with chronic schistosome infections also participated in
the study. They were deﬁned as individuals who were found
to be infected with S. japonicum by faecal examination
(Katz et al., 1972) during a population survey. They had
a history of water contact and S. japonicum infection but
were asymptomatic with no clinical features of disease.
Advanced patients (N = 34) were diagnosed if they pre-
sented with splenomegaly (Hackett degreeP II) (WHO,
2000. Ultrasound in schistosomiasis: A practical guide to
the standardised use of ultrasonography for the assessment
of schistosomiasis-related morbidity. In: Richter, J., Hatz,
C., Campagne, G., Bergquist, N.R., Jenkins, J.M. (Ed).
Second International Workshop, Niamey, Niger), hyper-
splenism and portal hypertension.
In addition, 20 subjects from non-endemic areas with no
known history of exposure to infection or liver disease were
recruited during routine health checks at a local clinic in
Yueyang, Hunan province. All control subjects tested neg-
ative for S. japonicum infection using the Kato-Katz thick
smear technique (Katz et al., 1972).
2.2. Serum processing
Venous blood samples (4–5 ml) were obtained from all
subjects with informed consent. Sera were separated within
Table 1
Composition and deﬁnition of clinically deﬁned schistosomiasis groups and controls
Disease phase Number of
individuals
Deﬁnition Mean age
(range)
Sex
M/F
Period of water
contact
EPG
(range)
Acute 35 Documented recent water contact 19.4 34/1 10.4 225
Tested positive for infection by Kato-Katz (Katz
et al., 1972)
(6–65) ±SD 16.3 days (6–2835)
Tested positive for infection by serology (MPHC,
2001)
Clinical symptoms (fever, and/or other symptoms)
Eosinophilia (P15% of total leukocyte count)
Chronic 45 Documented history of water contact 38.1 27/18 3.6 53
Tested positive for infection by Kato-Katz (7–68) ±SD 3.7 years (4–516)
History of re-infection
No or mild clinical symptoms
Severe 34 Documented history of water contact 47.1 24/10 N/A N/A
Presence of hypersplenism and portal hypertension (19–63)
Splenomegaly (Hackett degreeP II)
Non-exposed
controls
20 From non-endemic region 39.2 14/6 0 0
Tested negative for infection by Kato-Katz (25–62)
Healthy during routine check-up
N/A, not available; EPG, eggs per gram of faeces.
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80 C. Aliquots of all serum samples were then trans-
ported on dry ice to the Queensland Institute of Medical
Research, Brisbane and stored at 80 C until analysed.
An additional 0.5 ml of blood was collected into EDTA
tubes. Twenty microlitres of the blood was mixed with
380 ll eosin–acetone solution and incubated at room tem-
perature for 5–10 min. Eosinophils were counted using a
haemocytometer under a light microscope.2.3. Soluble receptor assays
Commercially available ELISA kits were used to mea-
sure serum levels of sTNFR-I, sTNFR-II and sICAM-1
(R&D Systems, Inc., Minneapolis). ELISAs were carried
out according to the manufacturer’s instructions and all
serum samples were measured in duplicate. Sample dilu-
tions were 1:25, 1:100 and 1:800 for TNFR-I, TNFR-II
and sICAM-1, respectively. Concentrations for each solu-
ble protein marker were determined from a serial-fold
diluted standard. The minimum levels of detection for each
assay were 6.25 pg/ml, 3.91 pg/ml and 7.81 pg/ml for
TNFR-I, TNFR-II and sICAM-1, respectively.2.4. Immunoglobulin assays
SEA and SWAP were prepared as described previously
(Li et al., 1999); antigen-speciﬁc IgG4 and total IgG levels
were measured by indirect ELISA. Brieﬂy, ELISA plates
(Nunc, Inc., Naperville) were coated with 5 lg/ml SEA
or 10 lg/ml SWAP in 50 mM carbonate buﬀer (pH 9.6)
and incubated overnight at 4 C. Plates were washed three
times with PBS (pH 7.6) containing 0.05% Tween 20 and
blocked using a PBS solution containing 1% BSA for 1 h atroom temperature. After a further three washes, primary
human serum samples were plated in duplicate in 1:100
and 1:200 dilutions for detection of IgG4 and total IgG,
respectively, and again incubated at room temperature
for 1 h. The plates were washed a further three times and
incubated for 1 h at room temperature with Streptavidin–
horseradish peroxidase (HRP)-labelled detection antibod-
ies in dilutions of 1:400 for IgG4 (Zymed, Inc., San Fran-
cisco) and 1:100,000 for total IgG (Bethyl, Inc.
Montgomery), respectively. After a ﬁnal three washes, the
detection reaction was developed using 3,3,5,5-tetramethyl-
benzidine (TMB) peroxidase substrate solution. After
30 min, the developed colour was stopped with 2 M
H2SO4 and the OD was measured at 450 nm using a Bio-
Rad ELISA reader. A blank PBS control was used on
each plate and the OD values were adjusted for plate-to-
plate variation by means of a positive internal standard.2.5. Statistical analysis
All data were analysed using SPSS 13.0. Analysis-of-
variance (ANOVA) was used to evaluate the overall signif-
icance between groups. Games–Howell post hoc tests were
performed to assess the pair-wise diﬀerences in protein
marker levels and immunoglobulin levels between the dif-
ferent clinically deﬁned groups and multivariate nominal
regression was used to estimate the strength of association
for each soluble protein marker. Results are expressed as
mean ng/ml for soluble protein markers and 95% conﬁ-
dence intervals (CIs) for each group. Antigen-speciﬁc
IgG4 and total IgG results are expressed as ODs. A log
transformation was applied to egg count data to normalise
the distribution and was used as a measure of infection
intensity (LnEPG). Correlations between markers and
Fig. 1. Median soluble ﬁbrosis marker levels (ng/ml) in diﬀerent Schis-
tosoma japonicum clinical disease groups compared with non-exposed
controls. Asterisks indicate signiﬁcant mean diﬀerences between each
disease group and controls as estimated using Games–Howell post-
analysis of variance tests.
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using the Pearson correlation coeﬃcient. All ﬁgures display
median protein marker or immunoglobulin levels for each
clinical disease group.
2.6. Ethical considerations
Informed consent was obtained from all participants
prior to blood collection. All patients who were stool-egg
positive were oﬀered a single dose of praziquantel at the rec-
ommended Word Health Organization (WHO) level
(40 mg/kg). They were subsequently re-tested to ensure
the infection was cleared. Ethical clearance for the study
was obtained from theMedical Ethics Committee of Hunan
Province and Queensland Institute of Medical Research.
3. Results
3.1. Soluble TNF receptors and ICAM-1 levels in the
diﬀerent clinically deﬁned disease groups
Elevated levels of sTNFR-I, sTNFR-II and sICAM-1
were observed in all clinically deﬁned schistosomiasis
groups compared with the control group (Fig. 1). Post hoc
tests were used to identify signiﬁcant diﬀerences between
the means for each marker between each clinical disease
group. The increase observed in chronically infected
patients compared with the control group was not signiﬁ-
cant for any of the three protein markers (P = 0.0567;
P = 0.0638 and P = 0.6996, respectively). Signiﬁcantly
higher mean levels of TNFR-I, sTNFR-II but not
sICAM-1 were observed in advanced patients compared
with controls (P = 0.0314; P = 0.00296; P = 0.1156, respec-
tively). Acute patients demonstrated the highest levels of all
three markers which were signiﬁcantly higher than the con-
trol group (P = 0.0427; P < 0.000001; P = 0.00011, respec-
tively) and signiﬁcantly higher sTNFR-II levels were
observed compared with advanced patients (P = 0.00008)
and chronic patients (P < 0.000001). To identify markers
most associated with disease, multivariate nominal regres-
sion was carried out. Likelihood ratio tests identiﬁed
sTNFR-I to be a non-signiﬁcant predictor of disease and
it was subsequently omitted from the ﬁnal model. The
regression analysis showed sTNFR-II and sICAM-1 to both
be signiﬁcantly associated with acute infection in the pres-
ence of the other (P = 0.0001 and P = 0.0156, respectively).
sTNFR-II showed the largest strength of association with
disease (OR = 1.099; 95% CI = 1.047–1.154). Both markers
were not signiﬁcant for any other disease stage.
3.2. Soluble protein correlations, infection intensity
and eosinophil counts
The Pearson correlation coeﬃcient was used to estimate
bi-variate correlations between the protein markers, infec-
tion intensity and eosinophil counts. All markers showed
signiﬁcant positive correlations with each other (Table 2),with sTNFR-I and sTNFR-II showing the highest correla-
tion (Pearson correlation = 0.723; P < 0.00001) thus dem-
onstrating a linear relationship between the two.
In the acute schistosomiasis group, highly signiﬁcant
positive correlations were found between eosinophil count
and infection intensity (Pearson correlation = 0.477;
P = 0.0072), and eosinophil count and the level of
sICAM-1 (Pearson correlation = 0.363; P = 0.0014).3.3. Immunoglobulin levels in the diﬀerent clinically deﬁned
disease groups
ANOVA post hoc tests showed all SEA- and SWAP-
speciﬁc total IgG and SEA-speciﬁc IgG4 levels were signif-
icantly higher in the acute, chronic and advanced groups
Table 2
Pearson correlation coeﬃcients and two-tailed signiﬁcances for correla-
tions between markers, infection intensity and eosinophil counts
sTNFR-II sICAM-1 LnEPG Eosinophil
count
sTNFR-I
Pearson correlation 0.723b 0.244b 0.164 0.013
Sig. (two-tailed) 0.000 0.000 0.134 0.949
sTNFR-II
Pearson correlation 0.368b 0.397b 0.04
Sig. (two-tailed) 0.000 0.000 0.822
sICAM-1
Pearson correlation 0.355b 0.363a
Sig. (two-tailed) 0.000 0.0442
LnEPG
Pearson correlation 0.477b
Sig. (two-tailed) 0.0072
sTNFR-I, soluble tumour necrosis factor receptor I; sICAM-I, soluble
intracellular adhesive molecule; LnEPG, log transformed data for eggs per
gram of faeces.
a Signiﬁcant at P < 0.05.
b Signiﬁcant at P < 0.01.
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globulin levels in acute and chronic patient groups were not
signiﬁcantly diﬀerent from each other. SEA-speciﬁc total
IgG measurements were signiﬁcantly lower in advanced
patients than in the acute and chronic disease groups
(P < 0.00001; P < 0.00001, respectively) as were SWAP-
speciﬁc total IgG levels (P = 0.0067; P = 0.0033, respec-
tively). Though antigen-speciﬁc IgG4 levels were higher
in acute and chronic patients than in the advanced patients
(Fig. 2), there was no signiﬁcant diﬀerence in SWAP-spe-
ciﬁc IgG4 between acute and advanced patients
(P = 0.0643). The mean level of SWAP-speciﬁc IgG4
observed in advanced patients compared with controls
was also not signiﬁcant (P = 0.0891).Fig. 2. Antigen-speciﬁc IgG4 and total IgG levels in diﬀerent Schistosoma japo
dilutions were 1:100 and 1:200 for the detection of IgG4 and total IgG levels,
disease group and controls as estimated using Games–Howell post-analysis of4. Discussion
Hepatic schistosomiasis is characterised by hepato-sple-
nic inﬂammation due to an immunopathological reaction
to deposition of schistosome eggs in the liver. The eggs
cause an immune reaction mediated by eosinophils and
macrophages and induce a delayed-type hypersensitivity
response, resulting in granuloma formation. This reaction
is a protective mechanism against the cytotoxic secretions
from the eggs; however, long-term infections may result
in portal hypertension and severe ﬁbrosis of the liver.
Although it is possible to detect some pathological features
and mild forms of diﬀuse ﬁbrosis using ultrasonography, it
can be diﬃcult, as in many cases there is no apparent sign
of disease (Kardorﬀ et al., 1996). Given the complexity of
the liver damage and the variety of measurements, ultra-
sound readings require expert training in order to correctly
determine disease severity and to monitor its progression.
In addition, ultrasound can be impractical and expensive
as a method of diagnosis and surveillance, particularly at
a community level or if used on a large scale.
Previous studies have investigated biochemical markers
in serum and plasma to evaluate their eﬃciency as potential
markers of liver damage. Procollagen peptide levels have
been shown to be elevated in schistosomiasis patients but
drop signiﬁcantly after praziquantel treatment rendering
them ineﬀectual in monitoring disease progression (Kard-
orﬀ et al., 1997). Further, overall sensitivity has been found
to be low despite high speciﬁcity (Burchard et al., 1998).
Hyaluronic acid (HA) has shown promising results corre-
lating positively with ultrasound (US) gradings in schisto-
somiasis japonica (Li et al., 2000; Zheng et al., 2005) and
schistosomiasis mansoni (Kopke-Aguiar et al., 2002). In
addition, HA levels were not found to be associated with
hepatitis infection, thus demonstrating its potential as a
marker of ﬁbrosis in patients with co-existing factors of
liver inﬂammation (Eboumbou et al., 2005).
Previously, studies of intestinal schistosomiasis mansoni
have implicated sICAM-1 in hepatic inﬂammation (Secornicum clinical disease groups compared with non-exposed controls. Serum
respectively. Asterisks indicate signiﬁcant mean diﬀerences between each
variance tests.
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known to play a role in granuloma formation (Ritter et al.,
1993; Ritter and McKerrow, 1996) and in the modulation
pathogenesis of hepatic and intestinal schistosomiasis
(Jacobs and Van Marck, 1998). In this study, we found
the highest levels of sICAM-1 to be amongst acute patients
which supports previous ﬁndings that elevated expression
of sICAM-1 is associated with egg deposition (Jacobs
and Van Marck, 1998). Markedly elevated levels of
sICAM-I were also observed in advanced schistosomiasis
japonica patients diagnosed with periportal ﬁbrosis (gra-
deP II), a feature previously reported also in hepatic
schistosomiasis mansoni (Mwatha et al., 1998). TNF-alpha
is thought to aggravate hepatic schistosomiasis (Henri
et al., 2002; Booth et al., 2004) and can induce shedding
of TNF-alpha receptors TNFR-I and TNFR-II (Aderka
et al., 1992; Aderka, 1996). The highly signiﬁcant correla-
tions of sTNFR-I with sTNFR-II in this study reﬂect this
relationship. Further, high levels of sTNFRs were observed
amongst the advanced schistosomiasis japonica patients
studied here, implying they could play a key role in the
development of hepatic ﬁbrosis. It is noteworthy that the
highest levels of these markers were observed in acute
patients, thus implicating them in the pro-inﬂammatory
response to granuloma formation and deposition in the
liver. Levels of sICAM-1 were also found to signiﬁcantly
correlate with eosinophil counts in acute patients, support-
ing previous ﬁndings that sICAM-1 is crucial in the regula-
tion of eosinophilic inﬂammation (Teixeira et al., 2001;
Forbes et al., 2006).
SEA-speciﬁc levels of IgG4 and total IgG were signiﬁ-
cantly elevated in all disease groups compared with non-
exposed controls. SEA- and SWAP-speciﬁc levels of IgG4
and total IgG were the same in chronic and acute schistoso-
miasis patients but were signiﬁcantly higher than in the
advanced group and thus are indicative of the presence of
infection and an active immune response to the parasite.
The levels were not signiﬁcantly diﬀerent between the acute
and chronic patients and thus, though associated with the
presence or absence of S. japonicum infection, they did not
diﬀerentiate between the diﬀerent clinical presentations of
schistosomiasis japonica. However, given the high levels of
these antibody isotypes in active infection, and the low levels
of soluble protein markers observed in chronic patients, the
results suggest a clear role for the latter in the granulomatous
reaction to egg deposition in acute and advanced patients.
The elevated levels of these markers in acute schistosomiasis
demonstrate the severity of morbidity in these patients.
We believe this work presents the ﬁrst investigation of
sICAM-1 and sTNFR (I and II) levels in human schistoso-
miasis japonica and supports ﬁndings from previous stud-
ies of hepatic schistosomiasis mansoni (Esterre et al., 1998;
Mwatha et al., 1998; Henri et al., 2002; Booth et al., 2004;
Coutinho et al., 2005). In conclusion, there appears to be a
strong correlation between sICAM-1, the sTNFRs and dis-
ease progression; the elevated levels of all three markers in
acute and advanced schistosomiasis patients togetherreﬂect an intense inﬂammatory response. Determination
of the levels in serum of sTNFR-II and sICAM-1 may
serve as a useful tool for the detection of acute schistosomi-
asis, and the onset and progression of advanced disease.
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